Elevated on-treatment levels of serum IFN-gamma is associated with treatment failure of peginterferon plus ribavirin therapy for chronic hepatitis C
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elevated on-treatment levels of serum IFN-gamma is associated with treatment failure of peginterferon plus ribavirin therapy for chronic hepatitis C
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-03-11
DOI
10.1038/srep22995
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus
- (2015) HEPATOLOGY
- EASL Recommendations on Treatment of Hepatitis C 2015
- (2015) JOURNAL OF HEPATOLOGY
- Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients
- (2015) Chi-Chieh Yang et al. PLoS One
- Peripheral blood mononuclear cells microRNA predicts treatment outcome of hepatitis C virus genotype 1 infection
- (2014) Edward Hsi et al. ANTIVIRAL RESEARCH
- The role of IL-28, IFN-γ, and TNF-α in predicting response to pegylated interferon/ribavirin in chronic HCV patients
- (2014) Asmaa Gaber Abdou et al. APMIS
- Cytokines and HCV-related autoimmune disorders
- (2014) Alessandro Antonelli et al. IMMUNOLOGIC RESEARCH
- Innate and adaptive immune responses in HCV infections
- (2014) Markus H. Heim et al. JOURNAL OF HEPATOLOGY
- Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver
- (2013) Stefan Wieland et al. HEPATOLOGY
- Clinical utility of host genetic IL-28B variants in hepatitis C virus genotype 1 Asian patients retreated with pegylated interferon plus ribavirin
- (2013) Chung-Feng Huang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Treatment efficacy of pegylated interferon plus ribavirin therapy in chronic hepatitis C patients with mixed genotype 1/2 infection
- (2013) Ching-I Huang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infection
- (2013) Barbara Oliviero et al. JOURNAL OF HEPATOLOGY
- Activation and Evasion of Antiviral Innate Immunity by Hepatitis C Virus
- (2013) Stacy M. Horner JOURNAL OF MOLECULAR BIOLOGY
- Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells
- (2013) Barbara Rehermann NATURE MEDICINE
- Virological Predictors of Response to Retreatment in Hepatitis C Genotype 2 Infected Patients
- (2013) Chung-Feng Huang et al. PLoS One
- APASL consensus statements and management algorithms for hepatitis C virus infection
- (2012) Masao Omata et al. Hepatology International
- Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype
- (2012) Chung-Feng Huang et al. JOURNAL OF CLINICAL VIROLOGY
- Innate immunity and HCV
- (2012) Markus H. Heim JOURNAL OF HEPATOLOGY
- Revisiting the Stopping Rule for Hepatitis C Genotype 1 Patients Treated with Peginterferon Plus Ribavirin
- (2012) Ming-Lung Yu et al. PLoS One
- Host interleukin-28B genetic variants versus viral kinetics in determining responses to standard-of-care for Asians with hepatitis C genotype 1
- (2011) Chung-Feng Huang et al. ANTIVIRAL RESEARCH
- Serum interleukin (IL)-10 and IL-12 levels and IL28B gene polymorphisms: pretreatment prediction of treatment failure in chronic hepatitis C
- (2011) Takeji Umemura et al. ANTIVIRAL THERAPY
- Sustained Virologic Response to Antiviral Therapy for Chronic Hepatitis C Virus Infection: A Cure and So Much More
- (2011) B. L. Pearlman et al. CLINICAL INFECTIOUS DISEASES
- Multi-center evaluation of the Abbott RealTime HCV Assay for monitoring patients undergoing antiviral therapy for chronic hepatitis C
- (2011) Johannes Vermehren et al. JOURNAL OF CLINICAL VIROLOGY
- Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin
- (2011) Chung-Feng Huang et al. JOURNAL OF HEPATOLOGY
- Association of Serum Cytokine Levels With Treatment Response to Pegylated Interferon and Ribavirin Therapy in Genotype 1 Chronic Hepatitis C Patients
- (2011) Suguru Yoneda et al. JOURNAL OF INFECTIOUS DISEASES
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quantitation of pretreatment serum interferon-γ-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response
- (2010) Jama M. Darling et al. HEPATOLOGY
- Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients
- (2010) Ming-Lung Yu et al. HEPATOLOGY
- Induction and Evasion of Innate Antiviral Responses by Hepatitis C Virus
- (2010) Stanley M. Lemon JOURNAL OF BIOLOGICAL CHEMISTRY
- Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
- (2010) Paul Y Kwo et al. LANCET
- Ribavirin mode of action in chronic hepatitis C: from clinical use back to molecular mechanisms
- (2010) Wolf Peter Hofmann et al. LIVER INTERNATIONAL
- Hepatitis C Virus Blocks Interferon Effector Function by Inducing Protein Kinase R Phosphorylation
- (2009) Urtzi Garaigorta et al. Cell Host & Microbe
- Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
- (2009) T. H. Mogensen CLINICAL MICROBIOLOGY REVIEWS
- Treatment of chronic hepatitis C in Asia: When East meets West
- (2009) Ming-Lung Yu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The global burden of hepatitis C
- (2009) Daniel Lavanchy LIVER INTERNATIONAL
- Alpha Interferon Induces Long-Lasting Refractoriness of JAK-STAT Signaling in the Mouse Liver through Induction of USP18/UBP43
- (2009) M. Sarasin-Filipowicz et al. MOLECULAR AND CELLULAR BIOLOGY
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
- (2009) Yasuhito Tanaka et al. NATURE GENETICS
- Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection
- (2009) R. E. Lanford et al. SCIENCE
- Th1 and Th2 cytokines are elevated in HCV-infected SVR(−) patients treated with interferon-α
- (2008) Lei Wan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial
- (2008) Ming-Lung Yu et al. HEPATOLOGY
- Interferon signaling and treatment outcome in chronic hepatitis C
- (2008) M. Sarasin-Filipowicz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started